<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        4-4-87
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1987
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        RESOCHIN TAB 250MG
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        CHLOROQUINE PHOSPHATE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        250
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        do not store above 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        5.1
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="BAYER AG" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            BAYER AG
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 527]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Abdulrauf Ibrahim Batterjee & Bros. Company
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            BAYER AG
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        P01BA01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Resochin contains the active substance chloroquine phosphate<br />Resochin Tablets is used for<br />&nbsp;treatment and prevention of malaria.<br />&nbsp;Resochin Tablets act on all four malaria germs that cause disease in<br />humans. The generally accepted guidelines on the appropriate use of<br />medicines for treating malaria (antimalarials) are to be observed.<br />&nbsp;chronic rheumatoid arthritis including juvenile chronic arthritis.<br />&nbsp;systemic lupus erythematosus.<br />Explanations<br />Malaria (marsh fever, tertian fever) is a severe, feverish disease whose germs<br />are transmitted by mosquitoes. Chronic rheumatoid arthritis and juvenile<br />chronic rheumatoid arthritis are connective tissue disorders that generally<br />mainly affect the joints, but internal organs may also be affected. Systemic<br />lupus erythematosus (lupus) is a connective tissue disorder affecting the skin<br />and also internal organs</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Some people being treated with Resochin tablets may develop mental health<br />problems such as unreasonable thoughts, hallucinations, feeling confused,<br />aggression, paranoia, feeling depressed, or having thoughts of harming or<br />killing themselves. This can also affect people who have never had such<br />problems before. If you or others notice any of these side effects (see section<br />4), seek medical advice immediately.<br />Do not take Resochin Tablets<br />if you are allergic to chloroquine phosphate or other 4-aminoquinolines<br />(including chloroquinoline phosphate, the active substance of Resochin<br />Tablets) or any of the other ingredients of this medicine listed in section<br />6,<br />R if you have been diagnosed with a disorder of the retina and/or impaired<br />field of vision,<br />&nbsp;if you have a blood formation disorder,<br />&nbsp;if you have glucose-6-phosphate dehydrogenase deficiency (a rare<br />disorder with possible destruction of red blood cells),<br />&nbsp;if you suffer from myasthenia gravis (severe muscle weakness) or<br />&nbsp;if you are pregnant or breast-feeding (except for the treatment of<br />malaria) (see section 2. &ldquo;Pregnancy and breast-feeding&rdquo;)</p><p>Warnings and precautions<br />Talk to your doctor or pharmacist before taking Resochin Tablets.<br />The insensitivity (so-called chloroquine resistance) of one malaria pathogen<br />(Plasmodium falciparum) is well documented. These data should be taken<br />into consideration before starting treatment with chloroquine, to ensure that<br />the treatment will be successful.<br />Simultaneous treatment with Resochin Tablets and other medicines for<br />treating rheumatoid arthritis (e.g. penicillamine), substances that have<br />a toxic effect on the liver (e.g. isoniazid, amiodarone, carbamazepine,<br />phenytoin, phenothiazines and ketoconazole) or MAO inhibitors (medicines<br />that inhibit a certain active substance in the body, e.g. tranylcypromine and<br />selegiline) should be avoided (see section 2. &ldquo;Other medicines and Resochin<br />Tablets&rdquo;).<br />Damage to the retina (retinopathy)<br />Before the start of prolonged treatment, an eye examination will be carried<br />out and is to be repeated at 3-monthly intervals. At the first signs of retinal<br />damage (inability to see the colour red), treatment must be discontinued.<br />Chloroquine should be administered only to children who are able to<br />undergo a colour vision test.<br />Permanent visual disturbances caused by Resochin-induced retinopathy are<br />possible during long-term treatment at high dosages. Retinal examinations<br />are recommended for patients receiving long-term therapy with Resochin.<br />Cumulative total doses of 1 g chloroquine per kg body weight or 50 to 100g<br />total dose can lead to retinal damage. In rare cases, retinopathy has been<br />induced by dosages recommended for malaria prevention. Within the context<br />of malaria prevention with Resochin, the onset of retinopathy is therefore<br />relevant only in long-term use (&gt; 5 years).<br />Impaired liver function<br />As Resochin is known to accumulate in the liver, patients with impaired liver<br />function may need to take a lower amount of Resochin Tablets.<br />Impaired kidney function<br />Resochin is partly excreted via the kidneys. For this reason, patients with<br />impaired kidney function may need to take a lower amount of Resochin<br />Tablets.<br />Kidney failure<br />Due to a lack of adequate experience, administration of Resochin in patients<br />with kidney failure (decrease in a certain laboratory value (creatinine<br />clearance) below 10 mL/min) is not to be recommended.<br />Nervous system<br />In patients suffering from epilepsy (seizures, muscle spasms with<br />unconsciousness), regular medical care is required.<br />Blood count<br />The blood count must also be checked before the start of long-term<br />treatment and checks are to be repeated at intervals of two months.<br />Metabolic disorders<br />Resochin should not be used in patients with porphyria (impaired production<br />of the red pigment in blood), as the use of chloroquine may cause symptoms to worsen.<br />Skin conditions<br />Resochin should not be used in patients with psoriasis, as the use of<br />chloroquine may cause symptoms to worsen.<br />QT prolongation<br />Resochin Tablets may cause heart rhythm disorders in some patients:<br />caution should be taken when using Resochin Tablets if you were born with<br />or have a family history of a prolonged QT interval, if you have acquired QT<br />prolongation (seen on ECG, electrical recording of the heart), if you have any<br />heart disorders or have a history of heart attack (myocardial infarction), if<br />you have a salt imbalance in the blood (especially low level of potassium or<br />magnesium, see section 2. &ldquo;Other medicines and Resochin Tablets&rdquo;).<br />If you experience palpitations or an irregular heartbeat during treatment,<br />you should inform your doctor immediately. The risk of heart problems may<br />increase with increases in the dose. Therefore, the recommended dose should<br />be followed.<br />Cardiotoxicity<br />At therapeutic doses and in the event of an acute overdose, chloroquine may<br />cause damage to the heart (cardiotoxicity).<br />Therapeutic doses may cause cardiomyopathy (a disease that weakens the<br />heart muscle and strength of the heartbeat). Cardiomyopathy may lead to<br />heart failure, which may be fatal in some cases.<br />In the event of an acute overdose, chloroquine may cause heart failure (the<br />heart muscle cannot pump strongly enough to supply the whole body with<br />blood) and serious heart rhythm disorders (see section 3. &ldquo;If you take more<br />Resochin Tablets than you should&rdquo;).<br />If you develop an irregular heartbeat during treatment with chloroquine, tell<br />your doctor immediately.<br />Hypoglycaemia<br />Resochin can cause a fall in the blood sugar level. Please ask your doctor<br />for information about signs and symptoms of low blood sugar. It may be<br />necessary to have your blood sugar level checked.<br />Long-term treatment in women of childbearing potential<br />Female patients taking Resochin Tablets in long-term use should use reliable<br />contraceptive protection during treatment and for 3 months thereafter (see<br />section 2. &ldquo;Pregnancy and breast-feeding&rdquo;).<br />Children and adolescents<br />There should be no long-term administration for the prevention of malaria<br />in children.<br />If Resochin is taken on a long-term basis, precautionary measures should<br />be taken in relation to the total dose (see section 3. &ldquo;How to take Resochin<br />Tablets&rdquo;).<br />Other medicines and Resochin Tablets<br />Tell your doctor or pharmacist if you are taking/using, have recently taken/<br />used or might take/use any other medicines.<br />Medicines known to affect the rhythm of your heart. This includes medicines<br />used for abnormal heart rhythm (antiarrhythmics), for depression (tricyclic<br />antidepressants), for psychiatric disorders (antipsychotics), for bacterial<br />infections or against malaria (e.g. halofantrine).<br />Taking Resochin Tablets with the following substances can affect the way<br />Resochin works:<br />&nbsp;Antacids (medicines for excessive stomach acid) and kaolin (medicine for<br />diarrhoea) can reduce the absorption of Resochin; there should therefore<br />be an interval of at least 4 hours between administering antacids or<br />kaolin and administering Resochin,<br />&nbsp;Phenylbutazone (active substance for gout and rheumatism) increases<br />the possibility of exfoliative dermatitis (skin inflammation with peeling<br />of the skin),<br />R Probenecid (active substance for gout) increases the probability of<br />sensitisation,<br />&nbsp;Corticosteroid derivatives (anti-inflammatory drugs) can aggravate<br />myopathies (muscle diseases) and cardiomyopathies (heart muscle<br />diseases),<br />&nbsp;Simultaneous treatment with Resochin Tablets and substances<br />that have a toxic effect on the liver (e.g. isoniazid, amiodarone</p><p>carbamazepine, phenytoin, phenothiazines and ketoconazole) or MAO<br />inhibitors (medicines to inhibit a certain active substance in the body,<br />e.g. tranylcypromine and selegiline) should be avoided (see section 2.<br />&ldquo;Warnings and precautions&rdquo;),<br />R Cimetidine (active substance for gastritis (inflammation of the stomach<br />lining) and stomach ulcers) can reduce the excretion of chloroquine,<br />R Mefloquine (active substance for malaria) and bupropion (active<br />substance used to stop smoking) can increase the risk of seizures,<br />R After metronidazole (an active substance used to treat a disease caused<br />by flagellate organisms (trichomonads)), an acute dystonic reaction<br />(change in muscle tone with slow movements) has been observed,<br />R Penicillamine (an antibacterial agent) can increase the risk of severe side<br />effects of the blood and/or kidneys, as well as skin reactions (see section<br />2. &ldquo;Warnings and precautions&rdquo;),<br />R Pyrimethamine and sulfadoxine (active substances for malaria)<br />significantly increase the risk of skin disorders.<br />Taking Resochin Tablets at the same time as the following substances can<br />affect the way these other medicines work:<br />R Reduced antibody formation when vaccinating against rabies with the<br />HDC vaccine; if simultaneous rabies vaccination is unavoidable, this<br />vaccination should be given intramuscularly. No negative effect on<br />routine vaccinations (tetanus, diphtheria, measles, poliomyelitis, typhoid<br />fever and tuberculosis) has been observed,<br />R Increase in the plasma digoxin concentration with glycoside poisoning<br />during long-term co-medication (risk of intoxication with digoxin, a heart<br />medication, when long-term co-administration was maintained),<br />R Increased effect of folic acid antagonists (methotrexate, an active<br />substance for cancer),<br />R Reduced effect of neostigmine and pyridostigmine bromide (muscle<br />stimulants),<br />R Increase in the plasma concentration of ciclosporin (active substance<br />used to suppress the body&rsquo;s immune system),<br />R Reduced absorption of ampicillin (an antibacterial agent; ampicillin<br />should be given at least 2 hours after administration of Resochin),<br />R The simultaneous use of praziquantel (agent to treat infestation with<br />flukes and tapeworms or lung and liver flukes) together with chloroquine<br />may result in a reduced concentration of praziquantel. The mechanism<br />and clinical significance of this interaction are unclear.<br />Resochin with alcohol<br />While taking Resochin Tablets, you should preferably not drink alcohol.<br />Pregnancy, breast-feeding and fertility<br />If you are pregnant or breast-feeding, think you may be pregnant or are<br />planning to have a baby, ask your doctor or pharmacist for advice before<br />taking this medicine.<br />Use in chronic rheumatoid arthritis and systemic lupus erythematosus<br />Pregnancy<br />Resochin Tablets must not be used in pregnancy, as they may cause organ<br />damage in the child. Pregnancy must be ruled out before the start of<br />treatment. During treatment and for three months afterwards, effective<br />contraceptive protection must be maintained.<br />Breast-feeding<br />Resochin Tablets must not be used during breast-feeding, as no adequate<br />experience is available and chloroquine phosphate, the active substance of<br />Resochin Tablets, passes into human milk.<br />Fertility<br />No data are available.<br />Use for the treatment and prevention of malaria<br />Pregnancy<br />During pregnancy, Resochin Tablets may be given only after a careful<br />assessment of the benefits and risks by your doctor. As a rule, he/she will<br />decide to use Resochin Tablets, as the malaria infection itself will harm the<br />unborn child.<br />Before starting use for the treatment and prevention of malaria, it must be<br />established whether the woman is pregnant. Once pregnancy has been ruled<br />out, effective contraceptive protection must be maintained during treatment<br />and for three months thereafter.<br />Breast-feeding<br />Women must not breast-feed (see above).<br />Fertility<br />No data are available.<br />Driving and using machines<br />Do not drive or use machines if you notice any side effects of Resochin<br />Tablets, such as headache, dizziness, drowsiness, states of confusion,<br />impairment of sharp vision and flickering blind spots before the eyes. These<br />may occur even with correct use. This applies particularly at the start of<br />treatment and in conjunction with alcohol.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take Resochin Tablets exactly as your doctor has told you. Check with<br />your doctor or pharmacist if you are not sure.<br />Total dose and general information for adults, children and adolescents<br />The total amount of 1 g chloroquine per kilogram of body weight (or a total<br />of about 50 - 100 g) taken over time can lead to retinal damage. For this<br />reason, the total dose should not exceed 50 g chloroquine. For children, the<br />normal gain in weight during the growth of the child should be considered<br />when calculating the maximum duration of treatment.<br />While considering the total dose, the total duration of treatment can<br />vary, depending on the patient&rsquo;s body weight and specific prescription<br />requirements. It is recommended, for the initial prescription, that the total<br />duration of treatment is calculated for you individually and that it is ensured<br />that the duration of treatment is recalculated each time there is a change<br />in the prescription parameters. You should be informed of the individually<br />calculated total duration of treatment. Special care should be taken not to<br />exceed the total duration of treatment.<br />Thereafter, prevention must be continued with a medicine not containing<br />chloroquine.<br />Please note that, in children, the limit for the total amount taken may<br />already have been reached after this medicine has been taken continuously<br />for 3 years.<br />In certain malaria zones, twice the total weekly amount is advisable for<br />short stays, with tablet-taking being spread evenly over 2 days. Please follow<br />your doctor&rsquo;s recommendations.<br />The recommended dose is:<br />To prevent malaria<br />Tablet-taking should be started 1 to 2 weeks before travelling to a malaria<br />zone. Whilst in a malaria zone, the tablets should be taken weekly on the<br />same day each week, and for a further 4 weeks after leaving such areas.<br />Adults<br />2 tablets once a week.<br />Use in children and adolescents<br />5 mg of chloroquine per kg of body weight once a week (equivalent to 8.1mg<br />of chloroquine phosphate per kg of body weight), up to the maximum dose<br />of 310 mg chloroquine.<br />Resochin junior Tablets 81 mg should be used in children with a body weight<br />of up to 25 kg.<br />Resochin Tablets 250 mg should be used in children with a body weight of<br />more than 25 kg in accordance with the dosage given in Table 1.<br />Table 1: Number of 250 mg tablets for preventing malaria (equivalent to<br />5 mg of chloroquine/kg of body weight once a week)</p><p><img alt="" src="data:image/png;base64,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" /></p><p>This medicine should not be used in children for a period of several months.<br />Treatment of malaria<br />To treat malaria infections caused by chloroquine-sensitive plasmodia,<br />treatment is started at a high initial dose, followed by 3 to 4 further single<br />doses of half that amount according to the tables below.<br />The single doses are calculated according to the patient&rsquo;s body weight. Per<br />kilogram of body weight, this amounts to 8 mg chloroquine phosphate<br />(active substance of Resochin Tablets). This results in the following overview<br />(see Table 2 and 3):<br />Adults<br />Table 2: Number of 250 mg tablets for treating malaria</p><p><img alt="" src="data:image/png;base64,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" /></p><p>&nbsp;</p><p>Use in children and adolescents<br />Resochin junior Tablets 81 mg should be used in children with a body weight<br />of up to 25 kg.<br />Resochin Tablets 250 mg should be used in children with a body weight of<br />more than 25 kg in accordance with the dosage given in Table 3.<br />Table 3: Number of 250 mg tablets for treating malaria</p><p>&nbsp;</p><p><img alt="" src="data:image/png;base64,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" /></p><p>&nbsp;</p><p>Treatment of chronic rheumatoid arthritis and systemic lupus<br />erythematosus:<br />The Resochin dose you require will be individually established for you by<br />your treating doctor. Due to the risk of eye disease affecting the retina,<br />the daily dose for long-term treatment should be no more than 4 mg<br />chloroquine phosphate (the active substance of Resochin Tablets) per<br />kilogram of body weight.<br />The success of treatment cannot be evaluated until after at least 4 to<br />12 weeks. Treatment will be discontinued by your doctor if there is no<br />improvement after 6 months.<br />Adults<br />A typical starting dose for adults is 250 mg of chloroquine phosphate<br />(equivalent to 155 mg of chloroquine) once daily.<br />Use in children and adolescents<br />The daily dose for children is 4 mg of chloroquine phosphate (equivalent to<br />2.5 mg of chloroquine) per kg of body weight. Due to the risk of retinopathy,<br />this dose should not be exceeded. Chloroquine should be administered only</p><p>to children who are able to undergo a colour vision test.<br />Dosage for patients with impaired liver or kidney function<br />Patients with impaired liver or kidney function may need a lower dose of<br />Resochin Tablets.<br />Method of administration<br />Please swallow the tablets whole with sufficient liquid (preferably a glass of<br />drinking water [200 mL]).<br />Duration of administration<br />Your doctor will decide on the duration of treatment.<br />There should be no long-term administration for the prevention of malaria<br />in children.<br />If you have the impression that the effect of Resochin Tablets is too strong or<br />too weak, talk to your doctor or pharmacist.<br />If you take more Resochin Tablets than you should<br />If you accidentally take double the single dose of Resochin Tablets, this<br />will have no effect on your further doses, i.e. you should continue to take<br />Resochin Tablets as normal.<br />If you accidentally take more Resochin Tablets than you should, tell a doctor<br />straight away. The following effects may happen: heart problems &ndash; may lead<br />to an irregular heartbeat.<br />If significantly excessive amounts of Resochin Tablets are taken, this can<br />lead to paralysing effects on the heart, circulation and breathing. Early signs<br />of intoxication are headache, visual disturbances and irregular heartbeat,<br />followed by seizures. If such signs of illness occur, you must be given<br />medical care immediately and admitted to hospital. Inform the nearest<br />available doctor as quickly as possible.<br />If a child has swallowed Resochin Tablets in an unsupervised moment, the<br />child must be made to vomit immediately and the nearest available doctor<br />must be notified.<br />Until the doctor arrives, the following measures are recommended:<br />A small child should be given as much water to drink as possible or,<br />even better, fruit juice diluted with water. He/she should then be placed<br />over the knee of an adult with the head and face downwards and the<br />abdomen gently compressed. Next, the child should be made to vomit by<br />irritating the back of its throat with a finger.<br />&nbsp;An older child should rapidly drink warm salt water (1 to 2 tablespoons<br />of salt in 1 glass of water). He/she should also be made to vomit by<br />irritating the back of his/her throat with a finger.<br />R Drinking and vomiting should be repeated until clear liquid is brought<br />up.<br />If you forget to take Resochin Tablets<br />For the prevention and treatment of malaria, please make up for a forgotten<br />dose if you realise that you have missed a dose shortly after your dosing<br />time. Similarly, if the next dosing time is nearer than the missed dosing time,<br />please make up for the forgotten dose, but postpone taking your next dose<br />for a while, so that there is a more even interval between doses.<br />In the treatment of chronic rheumatoid arthritis and systemic lupus<br />erythematosus, if you do not realise you have forgotten your dose until the<br />next day, do not make up for this dose. Simply continue to take Resochin<br />Tablets as normal.<br />If you stop taking Resochin Tablets<br />If you experience unpleasant side effects, please talk to your doctor<br />immediately about what can be done to combat them and whether any<br />other medicines are available for your treatment. Please do not stop taking<br />this medicine without consulting a doctor under any circumstances.<br />If you have any further questions on the use of this medicine, ask your<br />doctor or pharmacist</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Common (can affect up to 1 in 10 patients)<br />&nbsp;Loss of appetite<br />&nbsp;Clouding of the cornea, impaired vision, colour vision impairment<br />(reversible)<br />&nbsp;Gastro-intestinal and abdominal pain (pain in the gastro-intestinal and<br />stomach regions), diarrhoea, nausea, vomiting<br />&nbsp;Weight loss<br />Uncommon (can affect up to 1 in 100 patients)<br />&nbsp;Fear reactions<br />&nbsp;States of confusion, dizziness, headache, loss of tonicity, sleep problems,<br />discomfort (e.g. tingling or numb feeling), drowsiness, sleepiness<br />&nbsp;Temporary impairment to sharp vision<br />&nbsp;Drop in blood pressure, changes in heart function measurements (T-wave<br />depression on the ECG)<br />Rare (can affect up to 1 in 1,000 patients)<br />&nbsp;Agranulocytosis (severe decrease in certain white blood cells),<br />pancytopenia (severe decrease in all blood cells), thrombocytopenia<br />(severe decrease in blood platelets)<br />&nbsp;Worsening of porphyria (impaired formation of red blood pigment),<br />excretion of porphyrin (natural pigment) in the urine<br />&nbsp;Psychoses (mental disorders)<br />&nbsp;Cramp attacks, nerve-related muscle conditions<br />&nbsp;Damage to the retina (irreversible), blind spots, flickering<br />&nbsp;Loss of hearing, tinnitus (ringing in the ears)<br />&nbsp;Heart muscle disease (cardiomyopathy), which may be fatal in cases of<br />high-dose, long-term use (see section 2. &ldquo;Warnings and precautions&rdquo;)<br />&nbsp;Impaired liver function, rise in certain liver enzymes in the blood<br />&nbsp;Hair loss, worsening of psoriasis, hair pigmentation disorders<br />(hair bleaching or greying), sensitivity of the skin to light, itching,<br />skin pigmentation disorders (darkening of skin exposed to light),<br />discolouration of the lining of the mouth, skin rash<br />&nbsp;Rapid muscle fatigue with exertion, reduced muscle strength<br />&nbsp;Altered laboratory findings<br />Very rare (can affect up to 1 in 10,000 patients)<br />&nbsp;Eosinophilia (increase in certain white blood cells), acquired<br />methaemoglobinaemia (changes in haemoglobin, the red pigment that<br />gives blood its colour)<br />&nbsp;Drug-induced hypersensitivity syndrome (reported with symptoms such<br />as fever, skin rash with blistering, abdominal pain, diarrhoea, cough and<br />eosinophilia (increase in certain white blood cells), eosinophilia (increase<br />in certain white blood cells), also with deposition of such cells in tissues,<br />mainly the lung)<br />&nbsp;Acquired lipidosis (phospholipidosis) (increased accumulation of<br />intracellular phospholipids)<br />&nbsp;ECG changes (changes in heart function measurements)<br />&nbsp;Stevens-Johnson syndrome (severe, feverish skin rash also involving the<br />mucous membranes), toxic epidermal necrolysis (extensive detachment of<br />the upper layer of the skin and mucous membrane damage)<br />Not known (frequency cannot be estimated from the available data)<br />&nbsp;Allergic and anaphylactic reactions (acute immune system reactions<br />affecting the entire body) including urticaria (nettle rash) and<br />angioedema (swelling of the tissues under the skin and the mucous<br />membranes, mainly in the region of the eyelids and lips, in the throat<br />lining and on the tongue)<br />&nbsp;Drop in blood sugar levels (hypoglycaemia)<br />&nbsp;Abnormal heart rhythm, life-threatening, irregular heart rhythm (can be<br />seen on ECG) (see section 2. &ldquo;Warnings and precautions&rdquo;).<br />&nbsp;Feeling depressed or thinking about self-harm or suicide, anxiety, feeling<br />confused, irrational thoughts, paranoia, aggression, sleep disturbances,<br />restlessness, feeling elated or overstimulated, lack of concentration.<br />Reporting of side effects<br />If you get any side effects, talk to your doctor or pharmacist. This includes<br />any possible side effects not listed in this leaflet. By reporting side effects,<br />you can help provide more information on the safety of this medicine.<br />To report any side effect(s):<br />The National Pharmacovigilance Centre (NPC).<br />SFDA Call Center: 19999<br />E-mail: npc.drug@sfda.gov.sa<br />Website: https://ade.sfda.gov.sa</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.<br />Do not use Resochin Tablets after the expiry date which is stated on the<br />carton and push-through strip after &ldquo;EXP&rdquo;. The expiry date refers to the last<br />day of that month.<br />Storage conditions:<br />Not to be stored above 30&deg; C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>What Resochin Tablets contains:<br />R The active substance is chloroquine phosphate<br />1 Resochin Tablets film-coated tablet contains 250 mg chloroquine<br />phosphate (equivalent to 155 mg chloroquine).<br />R The other ingredients are:<br />Tablet core: maize starch, talc, magnesium stearate (Ph. Eur.).<br />Tablet coating: hypromellose, macrogol 4000, titanium dioxide (E 171).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Resochin Tablets are round, white and convex.
Resochin Tablets is available in original packs of 10 film-coated tablets.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Manufacturer and marketing<br />authorisation holder<br />Bayer AG<br />Kaiser-Wilhelm-Allee 1<br />51368 Leverkusen, Germany</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised: February 2021
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>r العلاج والوقاية من الملاريا<br />أقراص ريزوكين فعالة ضد جميع أنواع طفيليات الملاريا الأربعة التي تصيب الإنسان بالعدوى.<br />عموماً يجب مراعاة التوجيهات الإرشادية المقبولة بشأن الاستخدام المناسب للأدوية الخاصة<br />بعلاج الملاريا )مضادات الملاريا(.<br />r التهاب المفاصل المتعددة المزمن )ألتهاب المفاصل الروماتويدي(، يشمل التهاب المفاصل<br />الروماتويدي في الصغار.<br />r ذئبة حمراء عامة )ذِئْبَةٌ حُمَامِيَّةٌ مَجْموعِيَّة(.<br />شرح الأسباب<br />الملاريا )حمى المستنقعات، حمى الثلث( مرض خطير يتميز بارتفاع درجة الحرارة )حمى( ، العامل<br />المسبب لها ينقل عن طريق البعوض. التهاب المفاصل المتعددة المزمن و التهاب المفاصل المتعددة<br />الروماتويدي المزمن في الصغار هى أمراض النسيج الضام الذي يصيب عامة المفاصل فى الجزء<br />الأكبر و لكن مع ذلك يمكن أن يصيب أيضا أعضاء داخلية. الذئبة الإحمرارية العامة) طفح<br />الفراشة الجلدى ( ،هي مرض في النسيج الضام الذي يصيب الجلد و أيضاً أعضاء داخلية</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>قد يصاب بعض الأشخاص الذين يعالجون بأقراص ريزوكين بمشاكل نفسية مثل الأفكار غير<br />المعقولة، الهلوسة، الشعور بالارتباك، العدوانية، البارانويا )يعرف بجنون الارتياب(، الشعور<br />بالاكتئاب، أو التفكير في إيذاء أو قتل أنفسهم. أيضاً يمكن أن يصاب بهذا أشخاص لم يسبق<br />لهم أن واجهوا مثل هذه المشاكل من قبل. إذا لاحظت أنت أو غيرك أياً من هذه الآثار الجانبية<br />)انظر القسم 4(، فاطلب استشارة الطبيب المعالج على الفور.<br />لا تستخدم أقراص ريزوكين<br />r اذا كان لديك حساسية لفوسفات الكلوروكين أو لأي من ال 4-امينوكينولين الأخر )بما في<br />ذلك فوسفات الكلوروكينولين، المادة الفعالة لأقراص الريزوكين( أو أي من المكونات الأخرى<br />لهذا الدواء المدرجة في القسم 6،<br />r اذا كان لديك امراض فى شبكية العين و/أو خلل في مجال الإبصار تم تشخيصه،<br />r اذا كان لديك اضطرابات لها علاقة بتكوين خلايا الدم،<br />r اذا كان لديك نقص لإنزيم نازع الهيدروجين جلوكوز- 6 - فوسفات )مرض نادر يمكن أن يؤدى<br />لتدمير خلايا الدم الحمراء(،<br />r اذا كان لديك وهن عضلي وَخيم متقلص )ضعف خطير للعضلات( أو<br />r اذا كنت حامل أو أثناء فترة الرضاعة الطبيعية )مع استثناء علاج الملاريا( )أنظر اسفل، فى<br />الجزء بعنوان ، الحمل و الرضاعة الطبيعية(<br />التحذيرات والاحتياطات<br />تحدث إلى طبيبك المعالج أو الصيدلي قبل تناول أقراص ريزوكين.<br />من المعروف، وجود عدم استجابة احدى مسببات الملاريا للعلاج )المتصورة المنجلية - الاسم<br />العلمي Plasmodium falciparum ( )ما يسمى بمقاومة الكلوروكين( وهي موثقة جيداً.<br />لذلك يجب أن تؤخذ هذه البيانات في الاعتبار قبل بدء العلاج بالكلوروكين، لضمان نجاح العلاج.<br />يجب عدم تناول أقراص ريزوكين في نفس الوقت أثناء العلاج بأدوية أخرى لعلاج التهاب المفاصل<br />الروماتويدي )مثل البنسيلامين(، المواد التي لها تأثير سام على الكبد )مثل أيزونيازيد، أميودارون،<br />وكاربامازيبين، وفينيتوين، وفينوثيازين وكيتوكونازول( أو مثبطات الأوكسيداز الأحادي الأمين )أدوية<br />تثبط مادة فعالة معينة في الجسم، مثل ترانيلسيبرومين وسيليجيلين( )انظر القسم &laquo; .2 الأدوية<br />الأخرى وأقراص ريزوكين .)&raquo;<br />تلف فى الشبكية )اعتلال الشبكية(<br />سوف يتم فحص للعين قبل البدء فى العلاج لمدة طويلة ، الذى سوف يكرر فى فترات كل<br />ثلاثة شهور. يجب توقف العلاج عند أول علامة لتلف فى الشبكية )فقدان رؤية اللون الأحمر(.<br />يجب إعطاء الكلوروكين فقط للأطفال القادرين على اجتياز اختبار رؤية الألوان.<br />فى حالة العلاج لمدة طويلة بجرعات عالية من الريزوكين، هناك احتمال حدوث تلف دائم للرؤية<br />ناتج عن اعتلال الشبكية بسبب الريزوكين. يوصى بفحص الشبكية للمرضى ، الذين يستخدمون<br />العلاج بريزوكين لمدة طويلة. اجمالى الجرعات التراكمية التى تصل الى 1 جرام كلوروكين لكل<br />1 كيلوجرام من وزن الجسم أو اجمالى جرعات 50 الى 100 جرام كلوروكين يمكن أن تسبب<br />تلف الشبكية. الجرعات،الموصى بها للوقاية من الملاريا، نادرا ما تسبب اعتلال الشبكية. عندما<br />يستخدم ريزوكين كعلاج للوقاية ، الاصابة باعتلال الشبكية تكون مرتبطة بالاستخدام للعلاج<br />الوقائى لمدة طويلة) أكثر من 5 سنوات(.<br />اعتلال وظائف الكبد<br />حيث انه معروف أن الريزوكين يتراكم فى الكبد، المرضى الذين يعانون من خلل في وظائف الكبد<br />يمكن أن يحتاجون لجرعات أقل من أقراص ريزوكين.<br />اعتلال وظائف الكلى<br />يتم اخراج ريزوكين فى المقام الاول من خلال الكلى. لهذا ، فى المرضى الذين يعانون من خلل<br />وظائف الكلى، يمكن أن يحتاجون لجرعات مخفضة من أقراص ريزوكين.<br />الفشل الكلوى<br />بسبب نقص وجود الخبرة الكافية ، لاينصح باستخدام ريزوكين لمرضى الفشل الكلوى )بقيمة<br />معينة لاختبار المعمل )تصفية الكرياتينين( أقل من 10 مليليتر / دقيقة(<br />الجهاز العصبى<br />هناك احتياج لعمل فحص دورى منتظم للمرضى الذين يعانون من الصرع )نوبات، تشنجات<br />عضلية مصحوبة بفقدان الوعى(.<br />الصِّيغَةُ الدَّمَوِيَّة<br />الصِّيغَةُ الدَّمَوِيَّة يجب أن تفحص قبل بدء العلاج بريزوكين لمدة طويلة، وتكرر بعد ذلك كل فترة<br />شهرين .<br />خلل في الأيض<br />لا ينبغي استخدام الريزوكين في المرضى الذين يعانون من البورفيريا )ضعف إنتاج الصباغ الأحمر<br />في الدم(، لأن استخدام الكلوروكين قد يؤدي إلى أن تصبح الأعراض أسوأ.<br />الأمراض الجلدية<br />لا ينبغي استخدام الريزوكين في مرضى الصدفية، لأن استخدام الكلوروكين قد يؤدي إلى أن<br />تصبح الأعراض أسوأ.<br />إطالة فترة QT )هي فترة الزمن ما بين بداية موجة Q ونهاية موجة T في مخطط كهربية<br />القلب(<br />قد تسبب أقراص ريزوكين اضطرابات في ضربات القلب لدى بعض المرضى: يجب توخي الحذر عند<br />استخدام أقراص ريزوكين إذا كنت قد ولدت أو كان لديك تاريخ مرضي عائلي لإطالة فترة كيو<br />تي، إذا كان لديك إطالة مكتسبة لفترة كيو تي )يظهر في مخطط كهربية القلب، التسجيل<br />الكهربائي للقلب(، إذا كنت تعاني من أي اضطرابات في القلب أو كان لديك تاريخ مرضي<br />من النوبات القلبية )احتشاء عضلة القلب(، إذا كان لديك عدم توازن للملح في الدم )خاصة<br />انخفاض مستوى البوتاسيوم أو المغنيسيوم، انظر الجزء &laquo; .2 الأدوية الأخرى وأقراص الريزوكين .)&raquo;<br />إذا كنت تعاني من خفقان القلب أو عدم انتظام ضربات القلب أثناء العلاج، يجب عليك إبلاغ<br />طبيبك المعالج على الفور. قد يزداد خطر الإصابة بأمراض القلب مع زيادة الجرعة. لذلك، يجب<br />اتباع الجرعة الموصي بها.<br />التسمم القلبي<br />في الجرعات العلاجية وفي حالة الجرعة الزائدة الحادة، قد يتسبب الكلوروكين في تلف القلب<br />)السمية القلبية &ndash; التسمم القلبي(. قد يؤدي اعتلال عضلة القلب إلى فشل القلب، والذي قد<br />يكون مميتاً في بعض الحالات.<br />في حالة الجرعة الزائدة الحادة، قد يتسبب الكلوروكين في فشل القلب )لا تستطيع عضلة<br />القلب ضخ الدم بقوة كافية لتزويد الجسم كله بالدم( واضطرابات خطيرة في نظم القلب<br />)انظر القسم &laquo; .3 إذا كنت قد تناولت أقراص ريزوكين أكثر مما ينبغي .)&raquo;<br />إذا كنت تعاني من عدم انتظام ضربات القلب أثناء العلاج بالكلوروكين، أخبر طبيبك المعالج<br />على الفور.<br />انخفاض سكر الدم<br />قد يؤدي ريزوكين إلى انخفاض مستوى السكر في الدم. برجاء سؤال طبيبك عن معلومات حول<br />علامات وأعراض سكر الدم المنخفض قد يكون من الضروري القيام بفحص مستوى سكر الدم<br />لديك.<br />العلاج المستمر للنساء فى سن الإنجاب<br />المريضة التى تستخدام أقراص ريزوكين لفترة علاج طويلة ،يجب ان تستخدم وسائل منع الحمل<br />مضمونة الفاعلية أثناء فترة العلاج ولمدة ثلاثة شهور بعد ذلك )انظر القسم &laquo; ،2 الحمل و<br />الرضاعة الطبيعية . )&raquo;<br />الأطفال و المراهقين<br />يجب تجنب الاستخدام لفترة طويلة كوقاية من الملاريا في الأطفال.<br />إذا كان يتم تناول ريزوكين على أساس فترة طويلة من العلاج، فيجب اتخاذ تدابير وقائية فيما<br />يتعلق بالجرعة الإجمالية )انظر القسم &laquo; .3 كيفية تناول أقراص ريزوكين .)&raquo;<br />الأدوية الاخرى و أقراص ريزوكين:<br />أخبر طبيبك أو الصيدلي إذا كنت تتناول/تستخدم ، أو تناولت/استخدمت مؤخرًا أو قد تتناول/<br />تستخدم أي أدوية أخرى. .<br />الأدوية التي من المعروف أنها تؤثر على إيقاع قلبك. يشمل ذلك الأدوية المستخدمة في عدم<br />انتظام ضربات القلب )مضادات اضطراب النظم(، للاكتئاب )مضادات الاكتئاب ثلاثية الحلقات(،<br />للاضطرابات النفسية )مضادات الذهان(، للعدوى البكتيرية أو ضد الملاريا )مثل هالوفانترين(.<br />تناول أقراص ريزوكين في نفس الوقت مع الأدوية الآتية تؤثر على فاعلية ريزوكين :<br />r أدوية مضادة للحموضة )أدوية تستخدم للتخلص من زيادة الحامض المعدي( و الكاولين<br />)مادة تستخدم مضادة للإسهال( يمكن أن تقلل امتصاص الريزوكين ؛ لذلك يجب أن يكون<br />هناك فاصل من الوقت لا يقل عن 4 ساعات بين إعطاء أدوية الحموضة أو الكاولين و إعطاء<br />الريزوكين ؛<br />r فينيل بيوتازون )مادة فعالة تستخدم للتخلص من النقرس والروماتيزم( يزيد من امكانية<br />حدوث الْتِهابُ الجِلْدِ التَّقَشُّريّ )التهاب الجلد مع تقشر الجلد(؛<br />r بروبنسيد )مادة فعالة تستخدم للتخلص من النقرس( يزيد من احتمال حدوث الحساسية؛<br />r مشتقات الكورتيكوستيرويد )مواد فعالة، لها تأثير مضاد للالتهاب( يمكن أن يزيد الاعتلال<br />العضلي )مرض فى العضلات( و اعتلال عضلة القلب )مرض فى عضلة القلب(؛<br />r يجب تجنب العلاج المتزامن بأقراص الريزوكين والمواد التي لها تأثير سام على الكبد )أدوية<br />لها تأثير سام علي الكبد، مثل إيزونيازيد، أميودارون، الكربامازبين، فينيتوين، فينوثيازين و<br />كيتوكونازول( أو مثبطات المونو أمين أوكسيديز )منتجات طبية تثبط بعض المواد التي توجد<br />طبيعيا في الجسم، مثل ترانايلسيبرومين و سيليجيلين( )انظر القسم &laquo; 2 التحذيرات و<br />الاحتياطات ؛)&raquo;<br />r سيميتيدين )مادة فعالة تستخدم لعلاج التهاب المعدة وقرح المعدة( يسبب انخفاض إخراج<br />الكلوروكين؛<br />r ميفلوكين )مادة فعالة تستخدم لعلاج الملاريا( و بوبروبيون )مادة فعالة تستخدم للتوقف<br />عن التدخين( يمكن أن يزيد مخاطر حدوث التشنجات؛<br />r تفاعل لاتَوَتُّرِيَّ حاد )تغيير درجة توتر العضلات يعبر عنه بالحركات البطيئة( تم ملاحظته<br />بعد إعطاء المترونيدازول )مادة فعالة تستخدم لعلاج العدوى بجراثيم وحيدة الخلية)<br />تريكوموناس((؛</p><p>بنيسللامين )مادة فعالة تستخدم كمضاد للبكتريا( يمكن أن تزيد مخاطر التأثيرات الجانبية<br />الشديدة علي الدم و / أو الكلى وكذلك تفاعلات الجلد )انظر القسم &laquo; 2 التحذيرات و<br />الاحتياطات ؛)&raquo;<br />r بيريميثامين وسلفادوكسين )مواد فعالة تستخدم لعلاج الملاريا( تزيد بوضوح مخاطر تفاعلات<br />الجلد.<br />تناول أقراص ريزوكين في نفس الوقت مع الأدوية الآتية تؤثر على فاعلية الأدوية الأخرى:<br />r عن طريق انخفاض تكوين الأجسام المضادة عند التطعيم من السعار )داء الكلب( بلقاح<br />HDC( (. اذا لم يكن التطعيم المتَُواقِتٌ لايمكن تجنبه، إعطاء اللقاح يجب أن يكون بالعضل.<br />لم يتم رصد تأثير سلبى علي التطعيمات الروتينية ) تيتانوس، دفتيريا، الحصبة، شلل<br />الأطفال، حمى التيفود والدرن(،<br />r عن طريق ارتفاع تركيزات الديجوكسين في البلازما مع التسمم بالجليكوسيد في حالة<br />الإعطاء في نفس الوقت لفترة طويلة )مخاطر التسمم بدواء القلب ديجيوكسين، إذا تم<br />الإعطاء في نفس الوقت لفترات ممتدة من الوقت(؛<br />r عن طريق تشديد مفعول مضادات حامض الفوليك )ميثوتركسات، مادة فعالة تستخدم<br />لعلاج السرطان(؛<br />r عن طريق انخفاض تأثير النيوستجمين و بروميد البيريدوستيجمين )مادة فعالة تستخدم<br />كمنبهات للعضلات(؛<br />r عن طريق زيادة تركيزات البلازما للسيكلوسبورين )مادة فعالة تستخدم لخمد جهاز المناعة(<br />r عن طريق انخفاض امتصاص الامبيسللين )مادة فعالة تستخدم كمضاد للبكتريا؛ يجب<br />إعطاء الامبيسللين بعد ساعتين على الأقل من إعطاء الكلوروكين(؛<br />r قد يؤدي استخدام البرازيكوانتيل )عامل لعلاج الإصابة بالديدان المثقوبة والديدان الشريطية<br />أو المثقوبة في الرئة والكبد( في نفس الوقت مع استخدام الكلوروكين إلى انخفاض تركيز<br />البرازيكوانتيل. غير معروف كيف يتم ذلك التفاعل واهميته الاكلينيكية غير واضحة.<br />ريزوكين مع المشروبات الكحولية:<br />عندما تستخدم أقراص الريزوكين، لايجب شرب الكحول<br />الحمل والرضاعة الطبيعية والخصوبة:<br />إذا كنت حاملاً أو مرضعة، تعتقدين أنك حامل أو تخططين لإنجاب طفل، اسألي طبيبك أو<br />الصيدلي للحصول على المشورة قبل تناول هذا الدواء.<br />الاستخدام مع التهاب المفاصل المتعدد المزمن و الذئبة الحمراء العامة )ذِئْبَةٌ حُمَامِيَّةٌ مَجْموعِيَّة(:<br />الحمل<br />يجب عدم استخدام أقراص ريزوكين أثناء فترة الحمل لأنها يمكن تسبب تلف عضوي للجنين.<br />يجب اتخاذ تدابير لضمان أن المريضة غير حامل قبل البدء في العلاج. يجب استخدام وسائل<br />منع الحمل فعالة أثناء فترة العلاج ولمدة ثلاثة شهور بعد ذلك.<br />الرضاعة الطبيعية<br />لا يجب استخدام أقراص ريزوكين أثناء فترة الرضاعة الطبيعية حيث أنه لا يوجد بيانات كافية<br />في هذه الحالة، و فوسفات الكلوروكين، المادة الفعالة لأقراص ريزوكين، تمر في لبن الثدي.<br />الخصوبة<br />لا توجد بيانات متاحة.<br />الاستخدام فى العلاج والوقاية من الملاريا:<br />الحمل<br />يمكن فقط وصف أقراص ريزوكين أثناء فترة الحمل بعد بحث الطبيب بحرص شديد لنسبة<br />المخاطر/الفوائد. هذا سوف يقرره الطبيب عامة لصالح استعمال أقراص ريزوكين ، لأن إصابة<br />الملاريا نفسها تضر الطفل قبل ولادته .<br />يجب التيقن أن المريضة غير حامل قبل البدء في العلاج و الوقاية من الملاريا. بعد التيقن، يجب<br />استخدام وسائل منع حمل فعالة أثناء فترة العلاج ولمدة ثلاثة شهور بعد ذلك.<br />الرضاعة الطبيعية<br />غير مسموح بالرضاعة من الثدى )أنظر التعليمات السابقة(.<br />الخصوبة<br />لا توجد بيانات متاحة.<br />القدرة على القيادة وتشغيل الماكينات<br />لا تقوم بالقيادة أو تشغيل الماكينات.اذا عانيت من التأثيرات الجانبية لأقراص ريزوكين ، مثل<br />الصداع، دوخة، نعاس، حالات من الارتباك، وضعف التركيز فى الإبصار و تشوش الرؤية،<br />هذا ينطبق ايضا فى حالة الاستعمال كما تم وصفه تماما. هذا ينطبق أكثر ايضا عند بداية<br />العلاج و في حالة اقترانه بالكحول.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><img alt="" src="data:image/png;base64,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" /></p><p><img alt="" src="data:image/png;base64,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" /></p><p><img alt="" src="data:image/png;base64,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" /></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p><img alt="" src="data:image/png;base64,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" /></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>حفظ هذا الدواء بعيدًا عن أنظار ومتناول أيدي الأطفال.<br />لا تستخدم هذا الدواء بعد تاريخ انتهاء المفعول المطبوع على العبوة الكرتون و على الشرائط.<br />تاريخ الانتهاء هو آخر يوم في الشهر المشار إليه.<br />تعليمات التخزين<br />يحفظ عند درجة حرارة لا تزيد عن 30 درجة مئوية.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>ماذا تحتوي أقراص ريزوكين<br />r المادة الفعالة: فوسفات الكلوروكين<br />يحتوي كل قرص المغلفة علي 250 ملليجرام فوسفات الكلوروكين )المكافئ ل 155<br />ملليجرام كلوروكين(.<br />r المواد الأخرى هي:<br />قلب القرص : نشأ الذرة، تلك، ستيارات المغنيسيوم.<br />غلاف القرص :هيبروميللوز، ماكروجول 4000 ، ثنائى أكسيد التيتانيوم ) . )E171</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>ماهو شكل أقراص ريزوكين وماهى محتويات العبوة<br />ريزوكين أقراص مستديرة، بيضاء و محدبة<br />أقراص ريزوكين متوفرة فى عبوة 10 قرص</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>المصنع و حامل تصريح التسويق<br />باير ايه جي<br />قيصر-ويلهلم-آلي 1<br />5136 8 ليفركوزن، ألمانيا.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تمت آخر مراجعة لتعليمات الاستخدام في فبراير 2021 .
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Resochin Tablets 250 mg film coated tablet
Resochin junior Tablets 81 mg film coated tablet

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Resochin Tablets
1 film coated tablet contains 250 mg chloroquine phosphate (equivalent to 155 mg chloroquine).

Resochin junior Tablets
1 film coated tablet contains 81 mg chloroquine phosphate (equivalent to 50 mg chloroquine).

For the full list of excipients, see section 6.1

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film-coated tablet

Resochin Tablets
White, round, convex film coated tablet, with a cross-score on one side and Bayer Cross on the reverse

Resochin junior Tablets
White, round film coated tablet

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Resochin Tablets</u></p><p style="text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Treatment and prophylaxis of malaria.<br />Resochin is active against all four human pathogenic malaria species. The generally recognised guidelines for the appropriate use of medicinal products for the treatment of malaria must be observed.</p><p style="margin-left:28.35pt; text-indent:-28.35pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Rheumatoid arthritis including juvenile chronic arthritis.</p><p style="margin-left:28.35pt; text-indent:-28.35pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Systemic lupus erythematosus.</p><p>&nbsp;</p><p><u>Resochin junior Tablets</u></p><p style="text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Treatment and prophylaxis of malaria.<br />Resochin is active against all four human pathogenic malaria species. The generally recognised guidelines for the appropriate use of medicinal products for the treatment of malaria must be observed.</p><p style="margin-left:28.35pt; text-indent:-28.35pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Rheumatoid arthritis including juvenile chronic arthritis.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Posology</u></p><p><u>&nbsp;</u></p><p>Cumulative dose and general information for adults, children and adolescents</p><p>&nbsp;</p><p>Total cumulative dosages of 1&nbsp;g chloroquine per kg body weight (BW) or 50‑100&nbsp;g total dose may lead to retinal damage. A total cumulative dose of 50&nbsp;g chloroquine should therefore not be exceeded in adults. In children, the maximum cumulative dose should not exceed 1&nbsp;g per kg body weight, and the usual weight gain during the growth of the child should be taken into account for the maximum duration of treatment (see section&nbsp;4.4).</p><p>&nbsp;</p><p style="text-align:justify">Taking into account this total cumulative dose, the total duration of use may vary according to the patient&#39;s body weight and the individual dose. It is recommended that the total duration of use for the patient be calculated when the product is first prescribed and that recalculation of the duration of use in the event that the treatment parameters change in any way be ensured. The patient should be informed of the individually calculated total duration of use. Particular care should be taken to ensure that the total duration of use is not exceeded.</p><p>&nbsp;</p><p>After the individually calculated maximum duration is reached, prophylaxis with chloroquine must be stopped and, if necessary, continued with other active substances.</p><p>As a precaution, in the case of short stays in certain malaria‑affected areas, a doubled total weekly dose of 10&nbsp;mg per kg body weight over 2&nbsp;days (5&nbsp;mg/kg BW/day) may be advisable.</p><p><u>&nbsp;</u></p><p><strong><em><u>Malaria prophylaxis</u></em></strong></p><p>&nbsp;</p><p><strong>Table&nbsp;1: Posology and duration of use for malaria prophylaxis</strong></p><table cellspacing="0" cellpadding="0" border="1"><thead><tr><td colspan="2" style="vertical-align:top; width:266.55pt"><p style="text-align:center"><strong>Posology</strong></p></td><td rowspan="2" style="vertical-align:top; width:158.7pt"><p style="text-align:center"><strong>Duration of treatment</strong></p></td></tr><tr><td style="vertical-align:top; width:117.15pt"><p style="text-align:center"><strong>Adults</strong></p></td><td style="vertical-align:top; width:149.4pt"><p style="text-align:center"><strong>Paediatric population</strong></p></td></tr></thead><tbody><tr><td style="vertical-align:top; width:117.15pt"><p>500&nbsp;mg chloroquine phosphate (310&nbsp;mg chloroquine)</p><p>orally, once weekly.</p></td><td style="vertical-align:top; width:149.4pt"><p>8.1&nbsp;mg per kg body weight</p><p>Chloroquine phosphate (5&nbsp;mg/kg BW chloroquine)</p><p>orally, once weekly, the maximum dose is 500&nbsp;mg chloroquine phosphate (310&nbsp;mg chloroquine).</p></td><td style="vertical-align:top; width:158.7pt"><p>Start of administration 1&nbsp;to 2&nbsp;weeks before travel to malaria‑affected areas. To be taken weekly, always on the same day of the week, while staying in malaria‑affected areas and for 4&nbsp;weeks after leaving these areas.</p></td></tr></tbody></table><p>&nbsp;</p><p><em>Paediatric population</em></p><p>&nbsp;</p><p>Caution is required with regard to the cumulative dose while taking Resochin for prophylaxis because the individual limit for the duration of treatment may have already been reached after 3&nbsp;years of uninterrupted administration of this medicinal product.</p><p>Resochin should not be used as long‑term malaria prophylaxis in children.</p><p>&nbsp;</p><p>In children with a body weight of up to 25&nbsp;kg, Resochin junior Tablets should be used, according to the dosage indicated in Table&nbsp;2.</p><p>&nbsp;</p><p><strong>Table&nbsp;2: Number of junior tablets for malaria prophylaxis (equivalent to 5&nbsp;mg chloroquine/kg BW, once weekly)</strong></p><table cellspacing="0" cellpadding="0" border="0"><thead><tr><td colspan="2" style="vertical-align:top; width:297.65pt"><p style="text-align:center"><strong>Resochin junior Tablets 81 mg</strong></p></td></tr><tr><td style="vertical-align:top; width:1.85in"><p style="text-align:center"><strong>Body weight</strong></p><p style="text-align:center"><strong>(kg)</strong></p></td><td style="vertical-align:top; width:164.45pt"><p style="text-align:center"><strong>Weekly dose</strong></p><p style="text-align:center"><strong>(Number of film-coated tablets)</strong></p></td></tr><tr><td style="vertical-align:top; width:1.85in"><p style="text-align:center">3-5</p></td><td style="vertical-align:top; width:164.45pt"><p style="text-align:center">&frac12;</p></td></tr><tr><td style="vertical-align:top; width:1.85in"><p style="text-align:center">&gt;5-10</p></td><td style="vertical-align:top; width:164.45pt"><p style="text-align:center">1</p></td></tr><tr><td style="vertical-align:top; width:1.85in"><p style="text-align:center">&gt;10-15</p></td><td style="vertical-align:top; width:164.45pt"><p style="text-align:center">1&frac12;</p></td></tr><tr><td style="vertical-align:top; width:1.85in"><p style="text-align:center">&gt;15-20</p></td><td style="vertical-align:top; width:164.45pt"><p style="text-align:center">2</p></td></tr><tr><td style="vertical-align:top; width:1.85in"><p style="text-align:center">&gt;20-25</p></td><td style="vertical-align:top; width:164.45pt"><p style="text-align:center">2&frac12;</p></td></tr><tr><td style="vertical-align:top; width:1.85in"><p style="text-align:center">&gt;25-30</p></td><td style="vertical-align:top; width:164.45pt"><p style="text-align:center">3</p></td></tr><tr><td style="vertical-align:top; width:1.85in"><p style="text-align:center">&gt;30-35</p></td><td style="vertical-align:top; width:164.45pt"><p style="text-align:center">3&frac12;</p></td></tr><tr><td style="vertical-align:top; width:1.85in"><p style="text-align:center">&gt;35-50</p></td><td style="vertical-align:top; width:164.45pt"><p style="text-align:center">5</p></td></tr></thead></table><p>&nbsp;</p><p>In children with a body weight above 25&nbsp;kg, Resochin Tablets 250&nbsp;mg should be used, according to the dosage indicated in Table&nbsp;3.</p><p>&nbsp;</p><p><strong>Table&nbsp;3: Number of 250&nbsp;mg tablets for malaria prophylaxis (equivalent to 5&nbsp;mg chloroquine/kg BW, once weekly)</strong></p><table cellspacing="0" cellpadding="0" border="0"><thead><tr><td colspan="2" style="vertical-align:top; width:297.65pt"><p style="text-align:center"><strong>Resochin Tablets 250&nbsp;mg</strong></p></td></tr><tr><td style="vertical-align:top; width:1.85in"><p style="text-align:center"><strong>Body weight</strong></p><p style="text-align:center"><strong>(kg)</strong></p></td><td style="vertical-align:top; width:164.45pt"><p style="text-align:center"><strong>Weekly dose</strong></p><p style="text-align:center"><strong>(Number of film-coated tablets)</strong></p></td></tr><tr><td style="vertical-align:top; width:1.85in"><p style="text-align:center">&ge; 25 - &lt;38</p></td><td style="vertical-align:top; width:164.45pt"><p style="text-align:center">1</p></td></tr><tr><td style="vertical-align:top; width:1.85in"><p style="text-align:center">&ge; 38 - &lt;55</p></td><td style="vertical-align:top; width:164.45pt"><p style="text-align:center">1&frac12;</p></td></tr><tr><td style="vertical-align:top; width:1.85in"><p style="text-align:center">&ge; 55</p></td><td style="vertical-align:top; width:164.45pt"><p style="text-align:center">2</p></td></tr></thead></table><p>&nbsp;</p><p><strong><em><u>Treatment of malaria</u></em></strong></p><p>&nbsp;</p><p>The total dose for the treatment of malaria caused by chloroquine‑susceptible plasmodia is 40 to 50&nbsp;mg chloroquine phosphate (25 to 30&nbsp;mg chloroquine) per kg body weight.</p><p>&nbsp;</p><p>Initially, 16&nbsp;mg chloroquine phosphate (10&nbsp;mg chloroquine) per kg body weight is taken, and another 8&nbsp;mg chloroquine phosphate (5&nbsp;mg chloroquine) after 6&nbsp;hours. After that, 8&nbsp;mg chloroquine phosphate (5&nbsp;mg chloroquine) per day is given for the next 2 to 3&nbsp;days (see Table&nbsp;4).</p><p>&nbsp;</p><p><strong>Table&nbsp;4: Number of 250&nbsp;mg tablets for the treatment of malaria</strong></p><table cellspacing="0" cellpadding="0" border="0"><tbody><tr><td colspan="4" style="vertical-align:top; width:408.15pt"><p style="text-align:center"><strong>Resochin Tablets 250&nbsp;mg</strong></p></td></tr><tr><td style="vertical-align:top; width:85.0pt"><p style="text-align:center"><strong>Body weight</strong></p><p style="text-align:center"><strong>(kg)</strong></p></td><td style="vertical-align:top; width:99.25pt"><p style="text-align:center"><strong><u>Day&nbsp;1</u></strong></p><p style="text-align:center"><strong>1st dose</strong></p><p style="text-align:center"><strong>(Number of film-coated tablets)</strong></p></td><td style="vertical-align:top; width:110.5pt"><p style="text-align:center"><strong><u>Day&nbsp;1</u></strong></p><p style="text-align:center"><strong>2nd dose [6&nbsp;h later]</strong></p><p style="text-align:center"><strong>(Number of film-coated tablets)</strong></p></td><td style="vertical-align:top; width:113.4pt"><p style="text-align:center"><strong>Daily dose for <u>another 2 to 3&nbsp;days</u></strong></p><p style="text-align:center"><strong>(Number of film-coated tablets)</strong></p></td></tr><tr><td style="vertical-align:top; width:85.0pt"><p style="text-align:center">16</p></td><td style="vertical-align:top; width:99.25pt"><p style="text-align:center">1</p></td><td style="vertical-align:top; width:110.5pt"><p style="text-align:center">&frac12;</p></td><td style="vertical-align:top; width:113.4pt"><p style="text-align:center">&frac12;</p></td></tr><tr><td style="vertical-align:top; width:85.0pt"><p style="text-align:center">31</p></td><td style="vertical-align:top; width:99.25pt"><p style="text-align:center">2</p></td><td style="vertical-align:top; width:110.5pt"><p style="text-align:center">1</p></td><td style="vertical-align:top; width:113.4pt"><p style="text-align:center">1</p></td></tr><tr><td style="vertical-align:top; width:85.0pt"><p style="text-align:center">47</p></td><td style="vertical-align:top; width:99.25pt"><p style="text-align:center">3</p></td><td style="vertical-align:top; width:110.5pt"><p style="text-align:center">1&frac12;</p></td><td style="vertical-align:top; width:113.4pt"><p style="text-align:center">1&frac12;</p></td></tr><tr><td style="vertical-align:top; width:85.0pt"><p style="text-align:center">63</p></td><td style="vertical-align:top; width:99.25pt"><p style="text-align:center">4</p></td><td style="vertical-align:top; width:110.5pt"><p style="text-align:center">2</p></td><td style="vertical-align:top; width:113.4pt"><p style="text-align:center">2</p></td></tr><tr><td style="vertical-align:top; width:85.0pt"><p style="text-align:center">78</p></td><td style="vertical-align:top; width:99.25pt"><p style="text-align:center">5</p></td><td style="vertical-align:top; width:110.5pt"><p style="text-align:center">2&frac12;</p></td><td style="vertical-align:top; width:113.4pt"><p style="text-align:center">2&frac12;</p></td></tr><tr><td style="vertical-align:top; width:85.0pt"><p style="text-align:center">94</p></td><td style="vertical-align:top; width:99.25pt"><p style="text-align:center">6</p></td><td style="vertical-align:top; width:110.5pt"><p style="text-align:center">3</p></td><td style="vertical-align:top; width:113.4pt"><p style="text-align:center">3</p></td></tr></tbody></table><p>&nbsp;</p><p><em>Paediatric population</em></p><p><em>&nbsp;</em></p><p>In children with a body weight of up to 25&nbsp;kg, Resochin junior Tablets 81&nbsp;mg should be used, according to the dosage indicated in Table&nbsp;5.</p><p>&nbsp;</p><p><strong>Table&nbsp;5: Number of junior tablets for the treatment of malaria</strong></p><table cellspacing="0" cellpadding="0" border="0"><tbody><tr><td colspan="4" style="vertical-align:top; width:418.3pt"><p style="text-align:center"><strong>Resochin junior Tablets 81 mg</strong></p></td></tr><tr><td style="vertical-align:top; width:63.75pt"><p style="text-align:center"><strong>Body weight</strong></p><p style="text-align:center"><strong>(kg)</strong></p></td><td style="vertical-align:top; width:99.25pt"><p style="text-align:center"><strong><u>Day&nbsp;1</u></strong></p><p style="text-align:center"><strong>1st&nbsp;dose</strong></p><p style="text-align:center"><strong>(Number of film-coated tablets)</strong></p></td><td style="vertical-align:top; width:110.5pt"><p style="text-align:center"><strong><u>Day&nbsp;1</u></strong></p><p style="text-align:center"><strong>2nd&nbsp;dose [6&nbsp;h later]</strong></p><p style="text-align:center"><strong>(Number of film-coated tablets)</strong></p></td><td style="vertical-align:top; width:144.8pt"><p style="text-align:center"><strong>Daily dose for <u>another 2 to 3&nbsp;days</u></strong></p><p style="text-align:center"><strong>(Number of film-coated tablets)</strong></p></td></tr><tr><td style="vertical-align:top; width:63.75pt"><p style="text-align:center">4-5</p></td><td style="vertical-align:top; width:99.25pt"><p style="text-align:center">1</p></td><td style="vertical-align:top; width:110.5pt"><p style="text-align:center">&frac12;</p></td><td style="vertical-align:top; width:144.8pt"><p style="text-align:center">&frac12;</p></td></tr><tr><td style="vertical-align:top; width:63.75pt"><p style="text-align:center">&gt;5-7</p></td><td style="vertical-align:top; width:99.25pt"><p style="text-align:center">1&frac12;</p></td><td style="vertical-align:top; width:110.5pt"><p style="text-align:center">1</p></td><td style="vertical-align:top; width:144.8pt"><p style="text-align:center">1</p></td></tr><tr><td style="vertical-align:top; width:63.75pt"><p style="text-align:center">&gt;7-10</p></td><td style="vertical-align:top; width:99.25pt"><p style="text-align:center">2</p></td><td style="vertical-align:top; width:110.5pt"><p style="text-align:center">1</p></td><td style="vertical-align:top; width:144.8pt"><p style="text-align:center">1</p></td></tr><tr><td style="vertical-align:top; width:63.75pt"><p style="text-align:center">&gt;10-12</p></td><td style="vertical-align:top; width:99.25pt"><p style="text-align:center">2&frac12;</p></td><td style="vertical-align:top; width:110.5pt"><p style="text-align:center">1&frac12;</p></td><td style="vertical-align:top; width:144.8pt"><p style="text-align:center">1&frac12;</p></td></tr><tr><td style="vertical-align:top; width:63.75pt"><p style="text-align:center">&gt;12-15</p></td><td style="vertical-align:top; width:99.25pt"><p style="text-align:center">3</p></td><td style="vertical-align:top; width:110.5pt"><p style="text-align:center">1&frac12;</p></td><td style="vertical-align:top; width:144.8pt"><p style="text-align:center">1&frac12;</p></td></tr><tr><td style="vertical-align:top; width:63.75pt"><p style="text-align:center">&gt;15-20</p></td><td style="vertical-align:top; width:99.25pt"><p style="text-align:center">4</p></td><td style="vertical-align:top; width:110.5pt"><p style="text-align:center">2</p></td><td style="vertical-align:top; width:144.8pt"><p style="text-align:center">2</p></td></tr><tr><td style="vertical-align:top; width:63.75pt"><p style="text-align:center">&gt;20-25</p></td><td style="vertical-align:top; width:99.25pt"><p style="text-align:center">5</p></td><td style="vertical-align:top; width:110.5pt"><p style="text-align:center">2&frac12;</p></td><td style="vertical-align:top; width:144.8pt"><p style="text-align:center">2&frac12;</p></td></tr><tr><td style="vertical-align:top; width:63.75pt"><p style="text-align:center">&gt;25-30</p></td><td style="vertical-align:top; width:99.25pt"><p style="text-align:center">6</p></td><td style="vertical-align:top; width:110.5pt"><p style="text-align:center">3</p></td><td style="vertical-align:top; width:144.8pt"><p style="text-align:center">3</p></td></tr><tr><td style="vertical-align:top; width:63.75pt"><p style="text-align:center">&gt;30-35</p></td><td style="vertical-align:top; width:99.25pt"><p style="text-align:center">7</p></td><td style="vertical-align:top; width:110.5pt"><p style="text-align:center">3&frac12;</p></td><td style="vertical-align:top; width:144.8pt"><p style="text-align:center">3&frac12;</p></td></tr><tr><td style="vertical-align:top; width:63.75pt"><p style="text-align:center">&gt;35-40</p></td><td style="vertical-align:top; width:99.25pt"><p style="text-align:center">8</p></td><td style="vertical-align:top; width:110.5pt"><p style="text-align:center">4</p></td><td style="vertical-align:top; width:144.8pt"><p style="text-align:center">4</p></td></tr><tr><td style="vertical-align:top; width:63.75pt"><p style="text-align:center">&gt;40-45</p></td><td style="vertical-align:top; width:99.25pt"><p style="text-align:center">9</p></td><td style="vertical-align:top; width:110.5pt"><p style="text-align:center">4&frac12;</p></td><td style="vertical-align:top; width:144.8pt"><p style="text-align:center">4&frac12;</p></td></tr></tbody></table><p>&nbsp;</p><p>In children with a body weight above 25&nbsp;kg, Resochin Tablets 250&nbsp;mg should be used, according to the dosage indicated in Table&nbsp;6.</p><p>&nbsp;</p><p><strong>Table&nbsp;6: Number of 250&nbsp;mg tablets for the treatment of malaria</strong></p><table cellspacing="0" cellpadding="0" border="0"><tbody><tr><td colspan="4" style="vertical-align:top; width:418.3pt"><p style="text-align:center"><strong>Resochin Tablets 250&nbsp;mg</strong></p></td></tr><tr><td style="vertical-align:top; width:63.75pt"><p style="text-align:center"><strong>Body weight</strong></p><p style="text-align:center"><strong>(kg)</strong></p></td><td style="vertical-align:top; width:99.25pt"><p style="text-align:center"><strong><u>Day&nbsp;1</u></strong></p><p style="text-align:center"><strong>1st&nbsp;dose</strong></p><p style="text-align:center"><strong>(Number of film-coated tablets)</strong></p></td><td style="vertical-align:top; width:110.5pt"><p style="text-align:center"><strong><u>Day&nbsp;1</u></strong></p><p style="text-align:center"><strong>2nd&nbsp;dose [6&nbsp;h later]</strong></p><p style="text-align:center"><strong>(Number of film-coated tablets)</strong></p></td><td style="vertical-align:top; width:144.8pt"><p style="text-align:center"><strong>Daily dose for <u>another 2 to 3&nbsp;days</u></strong></p><p style="text-align:center"><strong>(Number of film-coated tablets)</strong></p></td></tr><tr><td style="vertical-align:top; width:63.75pt"><p style="text-align:center">&ge;25- &lt;38</p></td><td style="vertical-align:top; width:99.25pt"><p style="text-align:center">2</p></td><td style="vertical-align:top; width:110.5pt"><p style="text-align:center">1</p></td><td style="vertical-align:top; width:144.8pt"><p style="text-align:center">1</p></td></tr><tr><td style="vertical-align:top; width:63.75pt"><p style="text-align:center">&ge;38-&lt;55</p></td><td style="vertical-align:top; width:99.25pt"><p style="text-align:center">3</p></td><td style="vertical-align:top; width:110.5pt"><p style="text-align:center">1&frac12;</p></td><td style="vertical-align:top; width:144.8pt"><p style="text-align:center">1&frac12;</p></td></tr><tr><td style="vertical-align:top; width:63.75pt"><p style="text-align:center">&ge;55</p></td><td style="vertical-align:top; width:99.25pt"><p style="text-align:center">4</p></td><td style="vertical-align:top; width:110.5pt"><p style="text-align:center">2</p></td><td style="vertical-align:top; width:144.8pt"><p style="text-align:center">2</p></td></tr></tbody></table><p>&nbsp;</p><p><strong><em><u>Treatment of rheumatoid arthritis and systemic lupus erythematosus</u></em></strong></p><p>&nbsp;</p><p><em>Adults</em></p><p>The dosage is determined individually and, if necessary, adjusted in the course of therapy according to tolerability and effect. A typical starting dose in adults is 250&nbsp;mg chloroquine phosphate (equivalent to 155&nbsp;mg chloroquine) once daily.</p><p>Because of the risk of retinopathy during long‑term therapy, no more than 4&nbsp;mg chloroquine phosphate (equivalent to 2.5&nbsp;mg chloroquine) per kg body weight should be given per day.</p><p>At least 4 to 12&nbsp;weeks of treatment are required before the response to treatment can be assessed. Treatment must be discontinued if there has been no improvement after 6&nbsp;months.</p><p style="text-align:justify"><em>&nbsp;</em></p><p style="text-align:justify"><em>Paediatric population</em></p><p>The daily dose for children is 4 mg chloroquine phosphate (equivalent to 2.5 mg chloroquine) per kg body weight. This dose should not be exceeded because of the risk of retinopathy. Chloroquine should be used only in children who are capable of completing a colour vision test.</p><p>Treatment must be discontinued if there has been no improvement after 6&nbsp;months.</p><p>&nbsp;</p><p><em>Patients with hepatic and renal impairment</em></p><p>Patients with hepatic or renal impairment may require a dose adjustment (see section&nbsp;4.4).</p><p>&nbsp;</p><p><u>Method of administration</u></p><p>The film‑coated tablets must be swallowed whole with sufficient liquid</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                -	Hypersensitivity to the active substance, 4 aminoquinoline or to any of the excipients listed in section 6.1,
-	Retinopathy and visual field restrictions,
-	Diseases of the haematopoietic system,
-	Glucose 6 phosphate dehydrogenase deficiency (haemolytic anaemia, favism),
-	Myasthenia gravis and
-	Pregnancy and lactation (see section 4.6).

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Plasmodium falciparum</em> resistance to chloroquine is well documented, which is why epidemiological data must be taken into account before the start of chloroquine treatment.</p><p>&nbsp;</p><p>Concomitant therapy with Resochin and other disease‑modifying drugs for rheumatoid arthritis (e.g. penicillamine), hepatotoxic substances (e.g. isoniazid, amiodarone, carbamazepine, phenytoin, phenothiazines and ketoconazole) or monoamine oxidase inhibitors (e.g. tranylcypromine and selegeline) should be avoided (see section&nbsp;4.5).</p><p>&nbsp;</p><p><u>Suicidal behavior and psychiatric illnesses</u></p><p>Suicidal behavior and psychiatric illness have been observed in patients treated with chloroquine (see section 4.8), including in patients with no history of psychiatric illness. Patients should be advised to seek medical advice immediately if they develop psychiatric symptoms during treatment</p><p>&nbsp;</p><p><u>Retinopathy</u></p><p>Before the start of more prolonged oral therapy, an eye examination by an ophthalmologist must be carried out, which must be repeated at 3‑monthly intervals whilst treatment is ongoing. At the first signs of retinopathy (loss of red colour vision), treatment must be discontinued immediately.</p><p>The main recommended methods for retinopathy screening are automated visual field testing and (spectral domain) optical coherence tomography (SD‑OCT). If a colour vision test is the only available screening method for retinopathy, chloroquine should be used only in children who are capable of completing the colour vision test.</p><p>Irreversible impairment of vision caused by Resochin‑induced retinopathy is well documented in cases of long‑term therapy with high dosages. Retinal examinations are recommended for patients receiving long-term therapy with Resochin. Total cumulative doses of 1&nbsp;g per kg body weight chloroquine or of 50 to 100&nbsp;g total dose are associated with the occurrence of retinal damage (see section&nbsp;4.8). Retinopathy has rarely, if ever, been caused by dosages recommended for malaria prophylaxis. In connection with prophylaxis, retinopathy is thus only of importance in cases of long‑term use (&gt;&nbsp;5 years) of Resochin.</p><p>&nbsp;</p><p><u>Hepatic impairment</u></p><p>Because Resochin is known to accumulate in the liver, the dose may need to be adjusted for patients with hepatic impairment.</p><p>&nbsp;</p><p><u>Renal impairment</u></p><p>Resochin is partly excreted via the kidneys. The dose may therefore need to be adjusted for patients with renal impairment.</p><p>&nbsp;</p><p><u>Kidney failure</u></p><p>Owing to a lack of data, administration of Resochin cannot be recommended in patients with kidney failure (creatinine clearance &lt;&nbsp;10&nbsp;mL/min).</p><p>&nbsp;</p><p><u>Nervous system</u></p><p>Patients who suffer from epilepsy should receive regular medical care.</p><p>&nbsp;</p><p><u>Blood count</u></p><p>A blood count check must be carried out before the start of long‑term treatment and repeated at two‑monthly intervals.</p><p>&nbsp;</p><p><u>Metabolic disorders</u></p><p>Resochin should not be used in patients with porphyria because chloroquine use may lead to a deterioration in symptoms (see section&nbsp;4.8).</p><p>&nbsp;</p><p><u>Skin disorders</u></p><p>Resochin should not be used in patients with psoriasis because chloroquine use may lead to a deterioration in symptoms (see section&nbsp;4.8).</p><p>&nbsp;</p><p><u>Prolongation of the QTc interval</u></p><p>In some patients, chloroquine caused prolongation of the QTc&nbsp;interval.</p><p>Resochin should be used with caution in patients with congenital or proven acquired QT&nbsp;prolongation and/or known risk factors for prolongation of the QT interval, such as:</p><p style="text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->heart disease, e.g. heart failure, myocardial infarction</p><p style="text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->proarrhythmic conditions such as bradycardia (&lt;&nbsp;50&nbsp;bpm)</p><p style="text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->previous history of ventricular dysrhythmias</p><p style="text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->untreated hypokalaemia and/or hypomagnesaemia</p><p style="text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->and during concomitant use of substances that prolong the QT interval (see section&nbsp;4.5)</p><p>as this may be associated with an increased risk of ventricular arrhythmias, sometimes with a fatal outcome.</p><p>The magnitude of QT prolongation may increase with increasing medicinal product concentrations. The recommended dose should therefore not be exceeded (see also sections&nbsp;4.8 and 4.9).</p><p>If signs of a cardiac arrhythmia occur during treatment with Resochin, the treatment should be terminated and an ECG performed.</p><p>&nbsp;</p><p><u>Cardiomyopathy and cardiotoxicity</u></p><p>Chloroquine may lead to cardiotoxicity in therapeutic dosages and following an acute overdose.</p><p>Cases of cardiomyopathy leading to heart failure, sometimes with a fatal outcome, have been reported in patients receiving chloroquine therapy (see sections&nbsp;4.8 and 4.9). If signs and symptoms of cardiomyopathy occur during treatment with Resochin, the treatment should be terminated. Various degrees of atrioventricular block have also been reported at therapeutic dosages.</p><p>Following an acute overdose, chloroquine may lead to acute heart failure and severe arrhythmias (see section&nbsp;4.9 &quot;Overdose&quot;).</p><p>&nbsp;</p><p><u>Hypoglycaemia</u></p><p>Chloroquine has been shown to cause severe hypoglycaemia, including loss of consciousness, regardless of whether or not patients are being treated with antidiabetic agents. This can be life‑threatening. Patients being treated with chloroquine should be warned of the risk of hypoglycaemia and the associated clinical signs and symptoms. Patients who display clinical symptoms of hypoglycaemia during treatment with chloroquine should have their blood glucose levels checked and the need for an adjustment of their treatment reviewed.</p><p>&nbsp;</p><p><u>Long‑term use in women of childbearing potential</u></p><p>Female patients taking Resochin tablets for long‑term use should use a reliable method of contraception during treatment and for 3&nbsp;months thereafter (see section&nbsp;4.6).</p><p>&nbsp;</p><p><u>Long‑term use in children</u></p><p>Resochin should not be used for long‑term prophylaxis in children due to insufficient experience.</p><p>During administration of Resochin, precautions should be taken with regard to the cumulative dose in long‑term use (see section&nbsp;4.2).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Effects of other substances on Resochin</u></p><p style="margin-left:28.35pt; text-indent:-28.35pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Antacids and kaolin may reduce the absorption of chloroquine, and an interval of at least 4&nbsp;hours should therefore be left between ingestion of antacids/kaolin and administration of chloroquine</p><p style="margin-left:28.35pt; text-indent:-28.35pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Phenylbutazone increases the risk of exfoliative dermatitis</p><p style="margin-left:28.35pt; text-indent:-28.35pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Probenecid increases the likelihood of sensitisation</p><p style="margin-left:28.35pt; text-indent:-28.35pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Corticosteroid derivatives may exacerbate myopathy and cardiomyopathy</p><p style="margin-left:28.35pt; text-indent:-28.35pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Concomitant therapy with Resochin and other medicines with hepatotoxic potential (e.g. isoniazid, amiodarone, carbamazepine, phenytoin, phenothiazines and ketoconazole) or monoamine oxidase inhibitors (e.g. tranylcypromine and selegeline) should be avoided (see section&nbsp;4.4)</p><p style="margin-left:28.35pt; text-indent:-28.35pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Cimetidine may reduce the excretion of chloroquine</p><p style="margin-left:28.35pt; text-indent:-28.35pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Mefloquine and bupropion may increase the risk of seizures</p><p style="margin-left:28.35pt; text-indent:-28.35pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->An acute dystonic reaction has been observed following metronidazole</p><p style="margin-left:28.35pt; text-indent:-28.35pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Penicillamine increases the risk of severe haematological, renal or cutaneous adverse reactions (see section&nbsp;4.4)</p><p style="margin-left:28.35pt; text-indent:-28.35pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Pyrimethamine and sulfadoxine considerably increase the risk of skin reactions.</p><p>&nbsp;</p><p><u>Effects of Resochin on other substances</u></p><p style="margin-left:28.35pt; text-indent:-28.35pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Reduced antibody formation when vaccinating against rabies with the HDC vaccine; if simultaneous rabies vaccination is unavoidable, this vaccination should be given intramuscularly. No negative effect on routine vaccinations (tetanus, diphtheria, measles, poliomyelitis, typhoid fever and tuberculosis) has been observed,</p><p style="margin-left:28.35pt; text-indent:-28.35pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Increased plasma digoxin concentrations with glycoside intoxication in cases of long‑term co‑medication</p><p style="margin-left:28.35pt; text-indent:-28.35pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Potentiation of the effects of folic acid antagonists (methotrexate)</p><p style="margin-left:28.35pt; text-indent:-28.35pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Reduced effect of neostigmine and pyridostigmine bromide</p><p style="margin-left:28.35pt; text-indent:-28.35pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Increased plasma concentration of cyclosporin</p><p style="margin-left:28.35pt; text-indent:-28.35pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Reduced absorption of ampicillin (ampicillin administration should take place at least 2&nbsp;hours after chloroquine administration)</p><p style="margin-left:28.35pt; text-indent:-28.35pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->The concomitant use of chloroquine with praziquantel can lead to reduced plasma concentrations of praziquantel. The mechanism and clinical significance of this interaction are unclear.</p><p>&nbsp;</p><p><u>Medicinal products known to prolong the QT interval / capable of causing cardiac arrhythmias</u></p><p>Resochin should be used with caution in patients receiving medicinal products known to prolong the QT interval e.g. Class IA and III antiarrhythmic agents, tricyclic antidepressants, antipsychotic agents and some anti‑infectives because there is an increased risk of ventricular arrhythmia (see sections 4.4 and 4.9). Halofantrine should not be used with chloroquine.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Use in rheumatoid arthritis and systemic lupus erythematosus</u></p><p><u>Pregnancy</u></p><p>Resochin must not be used in pregnancy because it crosses the placental barrier and can cause organ damage in the foetus. Pregnancy must be ruled out before treatment. An effective method of contraception must be used during treatment and for three&nbsp;months thereafter.</p><p>&nbsp;</p><p><u>Breastfeeding</u></p><p>Resochin must not be used during breastfeeding because approx. 2 to 4% of the active substance passes into breast milk and accumulation in the infant is likely because of the long half‑life of Resochin. Although there have been no reports to date of harmful effects on the infant, women must not breastfeed because of the insufficient experience.</p><p>&nbsp;</p><p><u>Fertility</u></p><p>Data on fertility are not available.</p><p>&nbsp;</p><p><u>Use for malaria therapy and prophylaxis</u></p><p><u>Pregnancy</u></p><p>Where a woman is in an endemic area during pregnancy, a risk‑benefit assessment generally turns out in favour of Resochin use because malaria infection itself damages the foetus. Before the start of malaria therapy and prophylaxis, it must be established whether the woman is pregnant. If pregnancy is ruled out, an effective method of contraception must be used during treatment and for three&nbsp;months thereafter.</p><p>&nbsp;</p><p><u>Breastfeeding</u></p><p>Women must not breastfeed (see above).</p><p>&nbsp;</p><p><u>Fertility</u></p><p>Data on fertility are not available.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Because of central nervous system adverse effects (headaches, dizziness, drowsiness, confusional states, accommodation disorders, scintillating scotoma), even if used as intended, these medicinal products can alter the reaction capacity to such an extent that the ability to drive or use machines is impaired. This applies particularly at the start of treatment and in conjunction with alcohol</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Most of the adverse reactions observed are dose‑dependent. They occur mainly at plasma chloroquine concentrations above 250&nbsp;&micro;g/L.</p><p>&nbsp;</p><table cellspacing="0" cellpadding="0" border="1"><thead><tr><td style="vertical-align:top; width:85.05pt"><p style="text-align:center"><strong>System organ class</strong></p></td><td style="vertical-align:top; width:79.4pt"><p style="text-align:center"><strong>Common</strong></p><p style="text-align:center">(&ge;&nbsp;1/100, &lt;&nbsp;1/10)</p></td><td style="vertical-align:top; width:85.05pt"><p style="text-align:center"><strong>Uncommon</strong></p><p style="text-align:center">(&ge;&nbsp;1/1,000, &lt;&nbsp;1/100)</p></td><td style="vertical-align:top; width:90.7pt"><p style="text-align:center"><strong>Rare</strong></p><p style="text-align:center">(&ge;&nbsp;1/10,000, &lt;&nbsp;1/1,000)</p></td><td style="vertical-align:top; width:90.7pt"><p style="text-align:center"><strong>Very Rare</strong></p><p style="text-align:center">(&lt;&nbsp;1/10,000)</p></td><td style="vertical-align:top; width:82.2pt"><p style="text-align:center"><strong>Not known</strong></p><p style="text-align:center">(frequency cannot be estimated from the available data)</p></td></tr></thead><tbody><tr><td style="vertical-align:top; width:85.05pt"><p>Blood and lymphatic system disorders</p></td><td style="vertical-align:top; width:79.4pt"><p>&nbsp;</p></td><td style="vertical-align:top; width:85.05pt"><p>&nbsp;</p></td><td style="vertical-align:top; width:90.7pt"><p>Agranulocytosis, pancytopenia,</p><p>thrombocytopenia</p></td><td style="vertical-align:top; width:90.7pt"><p>Eosinophilia, methaemoglobinaemia</p></td><td style="vertical-align:top; width:82.2pt"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top; width:85.05pt"><p>Immune system disorders</p></td><td style="vertical-align:top; width:79.4pt"><p>&nbsp;</p></td><td style="vertical-align:top; width:85.05pt"><p>&nbsp;</p></td><td style="vertical-align:top; width:90.7pt"><p>&nbsp;</p></td><td style="vertical-align:top; width:90.7pt"><p>Drug‑induced hypersensitivity syndrome</p><p>reported (with symptoms such as fever, bullous rash, abdominal pain, diarrhoea, cough and eosinophilia),</p><p>pulmonary eosinophilia</p></td><td style="vertical-align:top; width:82.2pt"><p>Allergic and anaphylactic reactions, including urticaria and angio-oedema</p></td></tr><tr><td style="vertical-align:top; width:85.05pt"><p>Metabolism and nutrition disorders</p></td><td style="vertical-align:top; width:79.4pt"><p>Anorexia</p></td><td style="vertical-align:top; width:85.05pt"><p>&nbsp;</p></td><td style="vertical-align:top; width:90.7pt"><p>Exacerbation of porphyria (see section&nbsp;4.4),</p><p>porphyrinuria</p></td><td style="vertical-align:top; width:90.7pt"><p>Acquired lipidosis (phospholipidosis)</p></td><td style="vertical-align:top; width:82.2pt"><p>Hypoglycaemia (see section&nbsp;4.4)</p></td></tr><tr><td style="vertical-align:top; width:85.05pt"><p>Psychiatric disorders</p></td><td style="vertical-align:top; width:79.4pt"><p>&nbsp;</p></td><td style="vertical-align:top; width:85.05pt"><p>Anxiety reactions</p></td><td style="vertical-align:top; width:90.7pt"><p>Psychotic reactions</p></td><td style="vertical-align:top; width:90.7pt"><p>&nbsp;</p></td><td style="vertical-align:top; width:82.2pt"><p>Suicidal behavior, psychosis, aggression, delusions, paranoia, mania, attention deficit, sleep disorders</p></td></tr><tr><td style="vertical-align:top; width:85.05pt"><p>Nervous system disorders</p></td><td style="vertical-align:top; width:79.4pt"><p>&nbsp;</p></td><td style="vertical-align:top; width:85.05pt"><p>Confusional states,</p><p>dizziness,</p><p>headaches,</p><p>decreased tone,</p><p>sleep disorders,</p><p>par- and dysaesthesia,</p><p>light-headedness,</p><p>drowsiness,</p></td><td style="vertical-align:top; width:90.7pt"><p>Seizure,</p><p>peripheral neuropathy and polyneuropathy</p></td><td style="vertical-align:top; width:90.7pt"><p>&nbsp;</p></td><td style="vertical-align:top; width:82.2pt"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top; width:85.05pt"><p>Eye disorders</p></td><td style="vertical-align:top; width:79.4pt"><p>Corneal opacity,</p><p>visual disturbances,</p><p>impairment of colour vision</p><p>(reversible)</p></td><td style="vertical-align:top; width:85.05pt"><p>Temporary accommodation disorders</p></td><td style="vertical-align:top; width:90.7pt"><p>Retinopathy (irreversible) (see section&nbsp;4.4),</p><p>visual field defects,</p><p>scintillating scotoma</p></td><td style="vertical-align:top; width:90.7pt"><p>&nbsp;</p></td><td style="vertical-align:top; width:82.2pt"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top; width:85.05pt"><p>Ear and labyrinth disorders</p></td><td style="vertical-align:top; width:79.4pt"><p>&nbsp;</p></td><td style="vertical-align:top; width:85.05pt"><p>&nbsp;</p></td><td style="vertical-align:top; width:90.7pt"><p>Hearing loss,</p><p>tinnitus</p></td><td style="vertical-align:top; width:90.7pt"><p>&nbsp;</p></td><td style="vertical-align:top; width:82.2pt"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top; width:85.05pt"><p>Cardiac disorders</p></td><td style="vertical-align:top; width:79.4pt"><p>&nbsp;</p></td><td style="vertical-align:top; width:85.05pt"><p>Drop in blood pressure,</p><p>T‑wave depression in the ECG</p></td><td style="vertical-align:top; width:90.7pt"><p>Cardiomyopathies</p></td><td style="vertical-align:top; width:90.7pt"><p>&nbsp;</p></td><td style="vertical-align:top; width:82.2pt"><p>Atrioventricular block (first- to third-degree or bundle branch block), QT prolongation (see sections&nbsp;4.4 and 4.9)</p></td></tr><tr><td style="vertical-align:top; width:85.05pt"><p>Gastrointestinal disorders</p></td><td style="vertical-align:top; width:79.4pt"><p>Gastrointestinal and abdominal pain,</p><p>diarrhoea,</p><p>nausea,</p><p>vomiting</p></td><td style="vertical-align:top; width:85.05pt"><p>&nbsp;</p></td><td style="vertical-align:top; width:90.7pt"><p>&nbsp;</p></td><td style="vertical-align:top; width:90.7pt"><p>&nbsp;</p></td><td style="vertical-align:top; width:82.2pt"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top; width:85.05pt"><p>Hepatobiliary disorders</p></td><td style="vertical-align:top; width:79.4pt"><p>&nbsp;</p></td><td style="vertical-align:top; width:85.05pt"><p>&nbsp;</p></td><td style="vertical-align:top; width:90.7pt"><p>Hepatic impairment,</p><p>increase in transaminases</p></td><td style="vertical-align:top; width:90.7pt"><p>&nbsp;</p></td><td style="vertical-align:top; width:82.2pt"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top; width:85.05pt"><p>Skin and subcutaneous tissue disorders</p></td><td style="vertical-align:top; width:79.4pt"><p>&nbsp;</p></td><td style="vertical-align:top; width:85.05pt"><p>&nbsp;</p></td><td style="vertical-align:top; width:90.7pt"><p>Hair loss,</p><p>exacerbation of psoriasis (see section&nbsp;4.4),</p><p>hair pigmentation disorders</p><p>(bleaching or greying of hair),</p><p>photosensitivity reactions,</p><p>pruritus,</p><p>skin pigmentation disorders (dark discolouration of skin exposed to light),</p><p>discolouration of the oral mucosa,</p><p>rash</p></td><td style="vertical-align:top; width:90.7pt"><p>Stevens‑Johnson syndrome,</p><p>toxic epidermal necrolysis</p></td><td style="vertical-align:top; width:82.2pt"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top; width:85.05pt"><p>Musculoskeletal and connective tissue disorders</p></td><td style="vertical-align:top; width:79.4pt"><p>&nbsp;</p></td><td style="vertical-align:top; width:85.05pt"><p>&nbsp;</p></td><td style="vertical-align:top; width:90.7pt"><p>Myasthenic syndrome,</p><p>myopathy</p></td><td style="vertical-align:top; width:90.7pt"><p>&nbsp;</p></td><td style="vertical-align:top; width:82.2pt"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top; width:85.05pt"><p>General disorders and administration site conditions</p></td><td style="vertical-align:top; width:79.4pt"><p>weight loss</p></td><td style="vertical-align:top; width:85.05pt"><p>&nbsp;</p></td><td style="vertical-align:top; width:90.7pt"><p>&nbsp;</p></td><td style="vertical-align:top; width:90.7pt"><p>&nbsp;</p></td><td style="vertical-align:top; width:82.2pt"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top; width:85.05pt"><p>Investigations</p></td><td style="vertical-align:top; width:79.4pt"><p>&nbsp;</p></td><td style="vertical-align:top; width:85.05pt"><p>&nbsp;</p></td><td style="vertical-align:top; width:90.7pt"><p>Altered laboratory values</p></td><td style="vertical-align:top; width:90.7pt"><p>&nbsp;</p></td><td style="vertical-align:top; width:82.2pt"><p>&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p><p><u>Reporting of suspected adverse reactions</u></p><p>Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via:</p><p>&nbsp;</p><p><strong>To report any side effect(s):</strong></p><p>The National Pharmacovigilance Centre (NPC).</p><p>SFDA Call Center: 19999</p><p>E-mail: npc.drug@sfda.gov.sa</p><p>Website: https://ade.sfda.gov.sa</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Acute overdose</u></p><p>Acute poisoning with 3 to 8&nbsp;g chloroquine phosphate (equivalent to 2 to 5&nbsp;g chloroquine) can be fatal within 1 to 3 hours as a result of the paralysing effect on the heart, circulation and breathing. Symptoms of the prodromal stage of chloroquine intoxication are headache, visual disturbances and cardiac arrhythmias. A drop in blood pressure is followed by the development of shock with loss of consciousness and seizures, followed shortly by respiratory and cardiac arrest.</p><p>An acute Resochin overdose is capable of causing QT prolongation, ventricular arrhythmias and torsades de pointes tachycardia.</p><p>&nbsp;</p><p>In cases of severe intoxication, widening of the QRS complex, bradyarrhythmias, nodal rhythm, QT prolongation, atrioventricular block, ventricular tachycardia, torsades de pointes and ventricular fibrillation can occur.</p><p>&nbsp;</p><p><u>Chronic overdose</u></p><p>Chronic overdose can lead to fatal cardiomyopathy. If signs of cardiomyopathy occur, treatment with chloroquine should be discontinued immediately. Toxic chloroquine‑induced cardiomyopathy can be reversible if it is detected at an early stage (see section&nbsp;4.4). Chronic overdose can also lead to complete AV block.</p><p>&nbsp;</p><p><u>Therapeutic measures in the event of overdose</u></p><p>There is no known antidote. First, an attempt should be made, if it can be done promptly, to eliminate the toxin immediately by means of gastric lavage. Respiratory and circulatory support (epinephrine) must then be initiated early on. The seizures can be suppressed with benzodiazepines (diazepam), phenobarbital, if necessary by means of peripheral muscle relaxants with artificial ventilation. Haemodialysis is not suitable for treatment. It may be necessary to compensate for severe hypokalaemia.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Antimalarials, ATC code: P01BA01</p><p>&nbsp;</p><p>Chloroquine belongs to the 4‑aminoquinoline group of substances that are suitable for malaria treatment and prophylaxis. The antimalarial effect of chloroquine is attributable partly to the binding of chloroquine to porphyrins, which leads to the destruction/inhibition of asexual forms of non‑resistant plasmodia in the red blood cells and disrupts the development of sexual forms (gametocytes) in <em>P.&nbsp;ovale, P.&nbsp;vivax, P.&nbsp;malariae </em>and immature forms of <em>P.&nbsp;falciparum</em>. In combination with emetine derivatives, chloroquine is also effective against extraintestinal amoebiasis.</p><p>Chloroquine is an active substance that has a positive influence on the disease course of rheumatoid arthritis during long‑term treatment and can induce remission. Chloroquine displays no effects in most animal experimental models of inflammation. The antirheumatic effect of this substance might be due to immunosuppressive activity. Efficacy has also been proven in systemic lupus erythematosus</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Absorption</u></p><p>Chloroquine is rapidly and almost completely absorbed following oral administration. The maximum concentrations in the blood are reached after 3&nbsp;h. Plasma levels above 9.6&nbsp;&micro;g/L (&gt;&nbsp;30&nbsp;nmol/L), i.e. approximately 12.8 to 32&nbsp;&micro;g/L, are needed for malaria prophylaxis. Plasma levels of 96 to 192&nbsp;&micro;g/L are needed for the treatment of malaria.</p><p><u>&nbsp;</u></p><p><u>Bioavailability</u></p><p><u>&nbsp;</u></p><table cellspacing="0" cellpadding="0" border="1"><tbody><tr><td style="vertical-align:top; width:92.15pt"><p>&nbsp;</p></td><td style="vertical-align:top; width:99.25pt"><p style="text-align:center">155&nbsp;mg Resochin Tablets</p></td><td style="vertical-align:top; width:113.4pt"><p style="text-align:center">3 x 50&nbsp;mg Resochin junior Tablets</p></td><td style="vertical-align:top; width:99.2pt"><p style="text-align:center">Infusion of 155&nbsp;mg/L&nbsp;h Resochin Injection</p></td></tr><tr><td style="vertical-align:top; width:92.15pt"><p>Peak plasma concentration</p><p>(c<sub>max</sub>)</p></td><td style="width:99.25pt"><p style="text-align:center">28.45 &plusmn; 8.44&nbsp;&micro;g/L</p></td><td style="width:113.4pt"><p style="text-align:center">29.56 &plusmn; 11.36&nbsp;&micro;g/L</p></td><td style="width:99.2pt"><p style="text-align:center">232.3 &plusmn; 82.9&nbsp;&micro;g/L</p></td></tr><tr><td style="vertical-align:top; width:92.15pt"><p>Time to peak plasma concentration</p><p>(t<sub>max</sub>)</p></td><td style="width:99.25pt"><p style="text-align:center">5&nbsp;h</p></td><td style="width:113.4pt"><p style="text-align:center">2&nbsp;h</p></td><td style="width:99.2pt"><p style="text-align:center">1&nbsp;h</p></td></tr><tr><td style="vertical-align:top; width:92.15pt"><p>Area under the concentration‑time curve</p><p>(AUC)</p></td><td style="width:99.25pt"><p style="text-align:center">3045 &plusmn; 494&nbsp;&micro;g</p><p style="text-align:center">x h/L</p></td><td style="width:113.4pt"><p style="text-align:center">2995 &plusmn; 287.6&nbsp;&micro;g x h/L</p></td><td style="width:99.2pt"><p style="text-align:center">3453 &plusmn; 682.3&nbsp;&micro;g x h/L</p></td></tr></tbody></table><p style="text-align:center">Values indicated as arithmetic mean and scatter range, analysed n = 15</p><p>&nbsp;</p><p>Mean plasma level courses of Resochin i.v./oral in a concentration‑time graph</p><p><img src="data:image/png;base64,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" /></p><p><!--[if gte vml 1]><v:shapetype id="_x0000_t75"
 coordsize="21600,21600" o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe"
 filled="f" stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="_x0000_i1025" type="#_x0000_t75" style='width:438.75pt;
 height:313.5pt' o:ole="" fillcolor="window">
 <v:imagedata src="file:///C:/Users/GGQDY/AppData/Local/Temp/msohtmlclip1/01/clip_image001.wmz"
  o:title=""/>
</v:shape><![endif]--><!--[if !vml]--><!--[endif]--><!--[if gte mso 9]><xml>
 <o:OLEObject Type="Embed" ProgID="Unknown" ShapeID="_x0000_i1025"
  DrawAspect="Content" ObjectID="_1679234935">
 </o:OLEObject>
</xml><![endif]--></p><p>A&nbsp;-&nbsp;Resochin Tabl. 250&nbsp;mg/B&nbsp;-&nbsp;Resochin junior Tabl. 81&nbsp;mg/</p><p>C&nbsp;-&nbsp;Resochin Injection 50&nbsp;mg/mL&nbsp;i.v./D&nbsp;‑&nbsp;3&nbsp;x&nbsp;Resochin junior Tabl. 81&nbsp;mg</p><p>Arithmetic means (linear scales),</p><p>pharmacokinetically evaluated subjects, n = 15</p><p>Pharmacokinetics of chloroquine (&micro;g/L)</p><p>&nbsp;</p><p><u>Distribution</u></p><p>Chloroquine is distributed in the tissues in different concentrations. The volume of distribution is large. In whole blood, most of the chloroquine is bound to cellular elements. The portion found in the plasma is 50 to 60% bound to plasma proteins. In the course of treatment, chloroquine accumulates in the organs. The concentration found in the heart, lungs, kidneys and liver is more than 10&nbsp;times, in parenchymatous cells 100 to 500&nbsp;times and in pigmented cells up to 1000&nbsp;times the concentration in the plasma.</p><p>&nbsp;</p><p><u>Biotransformation</u></p><p>Metabolism takes place in the liver. The main metabolite is monodesethyl-chloroquine, which also still has antimalarial activity. It is excreted via the bile and kidneys.</p><p><u>&nbsp;</u></p><p><u>Elimination</u></p><p>40 to 70% of chloroquine is excreted unchanged via the kidneys.</p><p>It is eliminated only slowly from the deep compartments. The half‑life, calculated from a multicompartment system, is stated as 30 to 60&nbsp;days.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No regularly conducted studies of systemic toxicity, genotoxicity, carcinogenicity and embryotoxicity are available. Chloroquine is teratogenic in rats (various malformations). In another study, chloroquine induced eye defects in 47% of prenatally exposed rats.</p><p>&nbsp;</p><p>Electrophysiological <em>in vitro</em> studies show that chloroquine is a multi‑ion channel blocker that influences the major cardiac depolarisation and repolarisation flows at IC50 concentrations in the range of 0.22 to 20&nbsp;&micro;mol/L, from which a risk of QT prolongation/cardiotoxicity can be inferred (see section&nbsp;4.4).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Tablet core</u></p><p>Maize starch</p><p>Talc</p><p>Magnesium stearate (Ph.&nbsp;Eur.)</p><p>&nbsp;</p><p><u>Film coating</u></p><p>Hypromellose</p><p>Macrogol&nbsp;4000</p><p>Titanium dioxide (E171)</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3 years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not to be stored above 30&deg; C.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Folding boxes with PP/aluminium blister packs</p><p><u>Resochin Tablets</u></p><p>Pack of 20, 50, 100&nbsp;film‑coated tablets</p><p>&nbsp;</p><p><u>Resochin junior Tablets</u></p><p>Pack of 30&nbsp;film‑coated tablets</p><p>&nbsp;</p><p>Not all pack sizes may be marketed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Bayer AG
51368 Leverkusen
Germany

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                February 2021
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>